Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Classifica tra le azioni #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Prezzo delle azioni
$0.000001
Ultima sincronizzazione: 2023-12-13
Capitalizzazione di mercato
$23.51
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Allena Pharmaceuticals, Inc. (ALNAQ)

Categoria

Storico del prezzo dell'azione per Allena Pharmaceuticals, Inc. (ALNAQ)
Prezzo di chiusura più alto: $0.00 il 2023-12-01

Prezzo di chiusura più basso: $12.31 il 2017-11-01
Storico del prezzo dell'azione di Allena Pharmaceuticals, Inc. dal 2017 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 -99.48%
2022 -98.68%
2021 -49.81%
2020 -41.78%
2019 -68.12%
2018 -43.00%
2017 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR